The China Mail - Formerra to Supply Foster Medical Compounds in Europe

USD -
AED 3.672504
AFN 65.503991
ALL 80.193613
AMD 365.443623
ANG 1.789783
AOA 918.000367
ARS 1475.150612
AUD 1.415829
AWG 1.80125
AZN 1.70397
BAM 1.690479
BBD 2.011669
BDT 122.606854
BGN 1.696366
BHD 0.37668
BIF 2985.954449
BMD 1
BND 1.277583
BOB 11.640953
BRL 5.222404
BSD 0.998833
BTN 95.261679
BWP 13.45607
BYN 3.037988
BYR 19600
BZD 2.008816
CAD 1.38765
CDF 2273.000362
CHF 0.813512
CLF 0.023251
CLP 913.600415
CNY 6.743204
CNH 6.74452
COP 3115.519253
CRC 449.371191
CUC 1
CUP 26.5
CVE 95.306625
CZK 20.930304
DJF 177.864212
DKK 6.460604
DOP 58.464065
DZD 131.663425
EGP 49.854358
ERN 15
ETB 161.573793
EUR 0.864504
FJD 2.234204
FKP 0.737767
GBP 0.739153
GEL 2.610391
GGP 0.737767
GHS 10.937378
GIP 0.737767
GMD 73.503851
GNF 8773.931458
GTQ 7.6209
GYD 208.928649
HKD 7.84715
HNL 26.775574
HRK 6.512304
HTG 130.645231
HUF 313.830388
IDR 17828.1
ILS 2.955104
IMP 0.737767
INR 95.450504
IQD 1308.440296
IRR 1374587.503816
ISK 122.903814
JEP 0.737767
JMD 158.174511
JOD 0.70904
JPY 159.30404
KES 129.09806
KGS 87.450384
KHR 4041.661265
KMF 427.00035
KPW 900.000294
KRW 1416.470383
KWD 0.30868
KYD 0.832361
KZT 463.468603
LAK 22542.892951
LBP 89443.536886
LKR 332.365271
LRD 181.287005
LSL 16.158607
LTL 2.95274
LVL 0.60489
LYD 6.359825
MAD 9.264013
MDL 17.319677
MGA 4300.099399
MKD 53.182938
MMK 2099.658525
MNT 3597.556359
MOP 8.073123
MRU 40.112364
MUR 47.103741
MVR 15.450378
MWK 1731.967674
MXN 17.023504
MYR 4.085904
MZN 63.910377
NAD 16.158607
NGN 1359.570377
NIO 36.760448
NOK 9.442604
NPR 152.41886
NZD 1.697217
OMR 0.384504
PAB 0.998833
PEN 3.368858
PGK 4.486797
PHP 61.465038
PKR 277.41994
PLN 3.72275
PYG 5995.073253
QAR 3.641125
RON 4.526704
RSD 101.421842
RUB 84.182981
RWF 1468.77566
SAR 3.752773
SBD 8.048583
SCR 13.755996
SDG 600.503676
SEK 9.527038
SGD 1.279604
SHP 0.740866
SLE 24.503667
SLL 20969.499227
SOS 570.811185
SRD 37.974504
STD 20697.981008
STN 21.176369
SVC 8.739358
SYP 13001.999906
SZL 16.156273
THB 33.143038
TJS 9.223994
TMT 3.51
TND 2.928476
TOP 2.40776
TRY 47.867504
TTD 6.76693
TWD 32.021604
TZS 2646.873244
UAH 44.681879
UGX 3710.618436
UYU 40.019016
UZS 11890.747223
VES 770.109104
VND 26148.5
VUV 118.652424
WST 2.734432
XAF 566.970915
XAG 0.015456
XAU 0.000229
XCD 2.70255
XCG 1.800078
XDR 0.707052
XOF 566.970915
XPF 103.081378
YER 237.203589
ZAR 16.16923
ZMK 9001.203584
ZMW 18.87722
ZWL 321.999592
  • CMSD

    -0.0100

    21.58

    -0.05%

  • CMSC

    -0.0250

    21.45

    -0.12%

  • NGG

    -0.1500

    81.05

    -0.19%

  • RBGPF

    0.0000

    71.34

    0%

  • BCC

    -0.8900

    83.24

    -1.07%

  • BTI

    -0.2900

    57.06

    -0.51%

  • GSK

    -0.4785

    49.52

    -0.97%

  • BCE

    0.1500

    23.47

    +0.64%

  • RIO

    -0.4100

    95.68

    -0.43%

  • AZN

    -0.7900

    156.45

    -0.5%

  • VOD

    0.2000

    16.42

    +1.22%

  • JRI

    0.0635

    12.61

    +0.5%

  • RYCEF

    0.1300

    20.84

    +0.62%

  • BP

    0.2196

    42.53

    +0.52%

  • RELX

    -0.2400

    34.43

    -0.7%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

O.Yip--ThChM